Introduction
The poor efficacy of polysaccharide anti-meningococcal vaccines has stimulated a search for alternative protective antigens. Some outer-membrane proteins (OMPs) are antigenic both in vivo and in vitro and show inter-strain cross-reactivity, the transferrin (TO binding proteins (Tbps: TbpA and TbpB) being some of the most relevant [l, 21 . These particular proteins are of interest because anti-TbpB antibodies are bactericidal and protective and can block iron uptake from Tf, thus interfering with meningococcal growth [3] . The Tf-receptor complex (and its component proteins, TbpA and TbpB) has been identified and purified [4] , and studies on its structural, biochemical, functional and antigenic characteristics have been done [ l , 2, 4-61 . However, some uncertainties such as the TbpA:TbpB ratio, the necessity of both proteins for iron uptake, their antigenic heterogeneity and the efficacy of specific antibodies still persist. In gonococci, TbpA-defective mutants are incapable of Tf-iron internalisation and growth [6] , but mutants lacking TbpB can grow, although their iron-uptake efficiency is lowered [7] . In contrast, data obtained with meningoReceived 1 July 1997; revised version accepted 23 Dec. 1997 . Corresponding author: Professor M. T. Criado. cocci suggest that both types of mutants are unable to grow with Tf as the only iron source and both proteins seem to be necessary in this species [8] . This study tried to define more precisely the role of each Tbp in Tf binding and iron uptake in N rneningitidis.
Materials and methods
N rneningitidis mutants obtained and described by Irwin et al. [8] were kindly provided by Professor P. Borriello (Department of Microbiology, Queen's Medical Centre, Nottingham). The wild-type strain was N. rneningitidis B 16B6 and mutants were N 16T2K (TbpA+TbpB-), N16TlE (TbpA-TbpB+) and N16T 12EK (TbpA-TbpB-). The strains were maintained at -80°C and cultured in Mueller-Hinton medium (MH; iron sufficient), MH-EDDA (MH with 39 ,MM ethylene diaminodihydroxyacetic acid; iron restricted), or in an iron-restricted defined medium (mMBDM; used for uptake experiments) as described previously [9] . Binding of human transferrin was determined by a modified ELISA [ lo] . Kinetic assays and determinations of affinity and receptor copy numbers were done with '251-(Fe2)Tf and KCN-killed bacterial suspensions [3, 101. Uptake of 55Fe was measured in live bacterial suspensions by 55Fe2-Tf (25% saturation) [5] or 55Fe-complexes with organic acids [9] . The ability of mouse anti-TbpA serum (obtained by adsorption of antiTbpAB serum [3] with N16TlE cells) to block iron uptake from Tf was also determined in kinetic assays. Growth with human Tf as the only iron source was monitored in mMBDM medium containing 30 ,LLM FezTf [Ill.
Results and discussion
The characteristics of the binding of Tf by all strains are shown in Fig. 1 . The kinetics are compatible with the presence of specific receptors, except for the double mutant. The wild-type strain bound almost twice as much [1251]-Tf as the TbpA or TbpB mutants, which bound similar amounts of Tf (c. 1.6 pmoles/109 bacteria). The double mutant showed a very low binding, considered to be non-specific, and was not included in subsequent binding experiments. Binding data were analysed to estimate the number of receptor copies and their affinity constants (KJ. Scatchard plots were linear and adjusted to a model of a single, simple and homogeneous population (Hill's coefficients close to 1.0) with high correlation coefficients (C 3 0.95), both in the wild-type and in the isogenic mutants. numbers/cell and the corresponding affinity constants (Ka) of the strains. The uptake kinetics of 55Fe from Tf into the strains showed saturation at 15-20 min (data not shown). After 120min, the double mutant had not incorporated iron, and the TbpB and TbpA mutants had incorporated, respectively, 37% and 50% of the iron taken up by the wild-type strain. Iron uptake from low mol. wt ferric chelates (citrate, isocitrate, pyruvate, lactate and EDDA) was not affected by the mutations (data not shown). The effect of mouse anti-TbpA antibodies on the uptake of iron is also shown in Table  1 . Only the blocking effect in the wild-type strain (70%) was statistically significant (Mann-Whitney test; p < 0.05). Results of the growth assays done to study the effect of the mutations on the ability of N. meningitidis strains to use human Tf as the only source of iron are shown in Fig. 2 . The TbpB and the double knock-out mutants showed almost negligible growth, but the TbpA mutant grew up to an optical density only slightly lower than that of the wild-type strain. All strains were unable to grow in the medium lacking an external iron source.
The quantification of the binding of human Tf and the determination of the number and affinity of the receptors for this molecule in each mutant allowed the differentiation of the affinity of the TbpA and The results with regard to iron uptake and growth demonstrate that both the TbpA and TbpB defective mutants are capable of incorporating iron, but only the TbpA mutant gets sufficient iron for growth. This suggests that TbpB could have greater importance than TbpA for iron uptake although, until now, TbpA has been assumed to be the most important. Alternatively, the binding of Tf to TbpB in the TbpA mutant could alter the Tf molecule enough to induce iron release, which would then be intemalised by other non-specific mechanisms [9] .
Anti-TbpB antibodies are known to be bactericidal, protective to a variable degree, and capable of inhibiting meningococcal iron uptake and growth both in vivo and in vitro [3, 11, 151 . Ala'Aldeen and Borriello [ 161 suggested that only anti-TbpA antibodies were bactericidal, whereas Rokbi et al. [17] found that specific anti-TbpA antibodies did not bind to live meningococcal cells. Thus, the role of antiTbpA antibodies is not clear. In the present study, specific anti-TbpA antibodies bound to the wild-type strain and to the TbpB mutant and this binding was able to block iron uptake from Tf. The blockage was much lower in the TbpB mutant, probably due to the higher affinity for Tf in the mutant, which could cause a displacement of the antibodies by a competition phenomenon, or to the existence of conformational epitopes unrevealed in the absence of the TbpB molecule. The results of the present study, supported by data obtained with specific anti-TbpA antibodies, that show an almost complete cross-reactivity with 28
iV. meningitidis strains from different serogroups, serotypes and TbpB isotypes (unpublished observations), confirm that TbpA must not be discarded a priori in future vaccine formulations that incorporate the iron-regulated proteins.
